한국어
English
日本語
中文(简体)
Alesenza Capsule 150 mg (Alectinib Hydrochloride)
161.33mg
Hard capsule · Prescription medication
Korea Roche Co., Ltd.
Alectinib hydrochloride is an anticancer agent used for the treatment of ALK-positive non-small cell lung cancer.
MFDS ingredient code M264844
Alectinib hydrochloride is an anticancer agent that targets ALK (anaplastic lymphoma kinase) mutations. It is primarily used in the treatment of patients with ALK-positive non-small cell lung cancer, playing a role in inhibiting the growth and proliferation of cancer cells.
Alectinib hydrochloride blocks the activity of ALK protein within cancer cells, preventing the signaling that allows cancer cells to proliferate. As a result, the growth of cancer cells is inhibited, and the size of tumors may decrease.
Approved uses differ by product. Check each product's information for its actual use.
Alectinib hydrochloride has better brain penetration compared to other ALK inhibitors, making it effective for the treatment of patients with brain metastases. Additionally, it retains efficacy even in the presence of resistance, which distinguishes it from some other ALK inhibitors.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.